AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 71(2), 2004, pp. 187-189
Copyright © 2004 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SWEENEY, A. W.
Right arrow Articles by RIECKMANN, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SWEENEY, A. W.
Right arrow Articles by RIECKMANN, K. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Malaria

SHORT REPORT: THE ACTIVITY OF PAMAQUINE, AN 8-AMINOQUINOLINE DRUG, AGAINST SPOROZOITE-INDUCED INFECTIONS OF PLASMODIUM VIVAX (NEW GUINEA STRAINS)

ANTHONY W. SWEENEY, CHARLES R. B. BLACKBURN, AND KARL H. RIECKMANN
Institute for the Biotechnology of Infectious Diseases, University of Technology Sydney, Gore Hill, New South Wales, Australia; Darling Point New South Wales, Australia; Army Malaria Institute, Enoggera, Queensland, Australia

 

ABSTRACT

It was reported in 1946 that the administration of pamaquine during the incubation period delayed but did not prevent primary attacks of a New Guinea strain of Plasmodium vivax malaria. The observation that none of the four test subjects in this study had relapses has not previously been published and may have important implications for the evaluation of other 8-aminoquinoline compounds against relapsing vivax malaria.

Received December 11, 2003. Accepted for publication February 8, 2004.

Authors’ addresses: Anthony W. Sweeney, Institute for the Biotechnology of Infectious Diseases, University of Technology Sydney, Westbourne Street, Gore Hill, New South Wales 2065, Australia, Telephone: 61-2-4385-8774, Fax: 61-2-9514-4003, E-mail: tony. sweeney{at}uts.edu.au. Charles R. B. Blackburn, 64/10 Etham Avenue, Darling Point, New South Wales 2027, Australia, Telephone: 61-2-9363-4816, E-mail: ruthven{at}nd3d.com. Karl H. Rieckmann, Army Malaria Institute, Gallipoli Barracks, Enoggera, Queensland 4052, Australia, Telephone: 61-7-3332-4931, E-mail: Karl.Rieckmann{at}defence.gov.au.

Reprint requests: Anthony W. Sweeney, Institute for the Biotechnology of Infectious Diseases, University of Technology Sydney, West-bourne Street, Gore Hill, New South Wales 2065, Australia.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
A. A. Djimde, B. Fofana, I. Sagara, B. Sidibe, S. Toure, D. Dembele, S. Dama, D. Ouologuem, A. Dicko, and O. K. Doumbo
Efficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in Mali
Am J Trop Med Hyg, March 1, 2008; 78(3): 455 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
E. A. TEMU, I. KIMANI, N. TUNO, H. KAWADA, J. N. MINJAS, and M. TAKAGI
MONITORING CHLOROQUINE RESISTANCE USING PLASMODIUM FALCIPARUM PARASITES ISOLATED FROM WILD MOSQUITOES IN TANZANIA
Am J Trop Med Hyg, December 1, 2006; 75(6): 1182 - 1187.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. G. BREMAN, M. S. ALILIO, and A. MILLS
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT'S NEW, WHAT'S NEEDED: A SUMMARY
Am J Trop Med Hyg, August 1, 2004; 71(2_suppl): 1 - 15.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society of Tropical Medicine and Hygiene.